Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christoph Rehbach
Observed name:
Rehbach, Christoph
Institution:
MSH Medical School Hamburg – University of Applied Sciences and Medical University
Observed institutions:
MSH Medical School Hamburg – University of Applied Sciences and Medical University,
University Medical Center Hamburg-Eppendorf
ORCID:
0000-0003-2320-6709
Observed ORCID:
0000-0003-2320-6709
OpenAlex ID:
A5034974107
Identification of a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A
2013
·
Dominik Schröder
, Christoph Rehbach
, et al.
·
Biochemical and Biophysical Research Communications
·
13
Nuclear accumulation of SHIP1 mutants derived from AML patients leads to increased proliferation of leukemic cells
2018
·
Marcus M. Nalaskowski
, Patrick Ehm
, et al.
·
Cellular Signalling
·
11
Inositol hexakisphosphate increases the size of platelet aggregates
2018
·
Maria A. Brehm
, Ulrike Klemm
, et al.
·
Biochemical Pharmacology
·
9
PDF
Ikaros sets the threshold for negative B-cell selection by regulation of the signaling strength of the AKT pathway
2024
·
Patrick A. H. Ehm
, Stefan Horn
, et al.
·
Cell Communication and Signaling
·
7
Targeted hyperactivation of AKT through inhibition of ectopic expressed SHIP1 induces cell death in colon carcinoma cells and derived metastases
2023
·
Patrick A.H. Ehm
, Michael Linnebacher
, et al.
·
Cellular Signalling
·
6
Relevance of AKT and RAS Signaling Pathways for Antibody–Drug Conjugate Immunotherapies in Acute Lymphoblastic Leukemia
2025
·
Patrick A. H. Ehm
, Christoph Rehbach
·
Lymphatics
·
4
PDF
Characterization of the substrate specificity of the inositol 5-phosphatase SHIP1
2020
·
Nina Nelson
, Torsten Wundenberg
, et al.
·
Biochemical and Biophysical Research Communications
·
4
Receptor Reexpression after Hypermethylation: Novel Targets for Inhibitors and Antibody-Drug Conjugates in ALL
2026
·
Christoph Rehbach
, Patrick A. H. Ehm
·
Biocell
·
1
PDF
From Resistance to Vulnerability: Therapy-Induced Surface Receptor Plasticity in ALL as an Immunotherapeutic Opportunity
2026
·
Patrick A. H. Ehm
, Christoph Rehbach
·
Hemato
A novel 6-pyrophosphorylating IP6 kinase (IP6-6K) discovered in the protozoon Trichomonas vaginalis
2018
·
Torsten Wundenberg
, Marcus M. Nalaskowski
, et al.
·
Molecular and Biochemical Parasitology
Show more works
View as search
Works count:
13
Citation count:
55
H-index:
5
I10-index:
2
Year
Topic
Type